Literature DB >> 12629380

Temporal trends in radical prostatectomy complications from 1991 to 1998.

Jim C Hu1, Karen F Gold, Chris L Pashos, Shilpa S Mehta, Mark S Litwin.   

Abstract

PURPOSE: We performed a retrospective, longitudinal, population based study to ascertain whether radical prostatectomy outcomes improved after the diffusion of surgical innovations during the last decade.
MATERIALS AND METHODS: Using a 5% national random sample of Medicare beneficiaries we identified 12,079 men who underwent radical prostatectomy from 1991 to 1998. We analyzed relevant Medicare data to establish length of stay and the rate of in hospital complications (cardiac, respiratory, vascular, wound and genitourinary conditions) as well as the rate of anastomotic stricture, incontinence and impotence through 36 months after surgery. We performed multivariate logistic regression to control for age, race and geographic region when assessing the association of surgery year with outcomes of interest.
RESULTS: Between 1991 and 1998 the in hospital complication rate decreased from 38% to 30% and mean length of stay decreased from 8.1 to 5.1 days. Each value had significant regional variation throughout the United States. The 3-year incontinence rate decreased from 20% in 1991 to 4% in 1995. However, no meaningful trends were observed in the rate of impotence, anastomotic stricture, or placement of artificial urinary sphincters or penile prostheses. On multivariate analysis, older age (75 years or older, OR 1.68, p <0.01) and nonwhite race (OR 1.35, p <0.01) were associated with more in hospital complications. Nonwhite patients were also more likely to be diagnosed with impotence (OR 1.25, p <0.01) and undergo penile prosthesis placement (OR 1.5, p <0.01).
CONCLUSIONS: As urologists reach consensus on the ideal clinical characteristics for radical prostatectomy candidates, surgery in fewer elderly patients and the dissemination of surgical advances have been associated with shorter length of stay, fewer in hospital complications and a lower long-term incontinence rate. However, there is capacity for improvement, as evidenced by the unchanging rate of anastomotic stricture and impotence.

Entities:  

Mesh:

Year:  2003        PMID: 12629380     DOI: 10.1097/01.ju.0000056046.16588.e4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Comorbidities, treatment and ensuing survival in men with prostate cancer.

Authors:  Karim Chamie; Timothy J Daskivich; Lorna Kwan; Jessica Labo; Atreya Dash; Sheldon Greenfield; Mark S Litwin
Journal:  J Gen Intern Med       Date:  2011-09-21       Impact factor: 5.128

Review 2.  How to minimize lymphoceles and treat clinically symptomatic lymphoceles after radical prostatectomy.

Authors:  Hak J Lee; Christopher J Kane
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

3.  Racial Differences in Urinary Incontinence Prevalence, Overactive Bladder and Associated Bother among Men: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Aelia Akbar; Kiang Liu; Erin D Michos; Linda Brubaker; Talar Markossian; Michael P Bancks; Holly Kramer
Journal:  J Urol       Date:  2020-09-10       Impact factor: 7.450

Review 4.  What's a man to do? Treatment options for localized prostate cancer.

Authors:  Tom Pickles
Journal:  Can Fam Physician       Date:  2004-01       Impact factor: 3.275

5.  Novel use of the capio urethral anastomotic suturing device: a 50-case assessment.

Authors:  Elleson A Schurtz; Jhanelle Markes; Mark R Newton; James A Brown
Journal:  Curr Urol       Date:  2014-02-10

6.  [Stress incontinence after prostatectomy in treatment reality: results from a rehabilitation clinic].

Authors:  V Lent; H M Schultheis; L Strauß; M K Laaser; S Buntrock
Journal:  Urologe A       Date:  2013-08       Impact factor: 0.639

7.  Male urinary incontinence: prevalence, risk factors, and preventive interventions.

Authors:  Tatyana A Shamliyan; Jean F Wyman; Ryan Ping; Timothy J Wilt; Robert L Kane
Journal:  Rev Urol       Date:  2009

8.  [Fistula surgery].

Authors:  C M Rosenbaum; M W Vetterlein; M Fisch
Journal:  Urologe A       Date:  2020-04       Impact factor: 0.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.